Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Novartis and Quark sign gene silencing deal

August 19, 2010 Research and Development Novartis, Quark, SiRNA, rnai

Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …
News

Cell therapy industry partnership launched

August 18, 2010 Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
News

Contract research news in brief

August 18, 2010 Research and Development Anavex, Cyprotex, Synexus

UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …
News

Lilly abandons late stage Alzheimer’s drug

August 17, 2010 Research and Development Alzheimer's, lilly

Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
News
StemCellPinheadWeb

Regenerative medicine: small steps towards the great leap forward

August 16, 2010 Research and Development GSK, Pfizer, Stem cells, regenerative medicine

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …
Feature

Merck signs Alzheimer’s deal with Alectos

August 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
News
Amgen

Amgen’s Vectibix fails late stage trial

August 12, 2010 Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
News

Pharminox promotes Dr Marc Hummersone

August 12, 2010 Research and Development Pharminox, appointment, research and development

Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …
Appointment

US biotech investment doubles

August 11, 2010 Research and Development biotech, funding

Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …
News

Quintiles relocates European headquarters

August 11, 2010 Research and Development, Sales and Marketing Quintiles

Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …
News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1

August 11, 2010 Research and Development Kinapse, life sciences, pharma

Valuations are essential components of effective transactions in the life sciences industry
Feature
White paper

Sanofi signs personalised medicine alliance

August 11, 2010 Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …
News

Medical Affairs at the centre of life sciences innovation

August 11, 2010 Research and Development Kinapse, Medical Affairs

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Feature
Sir_John_Savill

Sir John Savill to head up MRC

August 11, 2010 Research and Development MRC, appointment, research and development

The Medical Research Council has appointed Sir John Savill as chief executive and deputy chair with effect from 1 October. …
Appointment

Elan halts separation plans

August 10, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elan

Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026